Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
11,914,481
-
Share change
-
-8,523
-
Total reported value
-
$2,683,001
-
Price per share
-
$0.22
-
Number of holders
-
24
-
Value change
-
-$309,582
-
Number of buys
-
11
-
Number of sells
-
11
Institutional Holders of ZOSANO PHARMA CORP - COM NEW (ZSAN) as of Q1 2022
As of 31 Mar 2022,
ZOSANO PHARMA CORP - COM NEW (ZSAN) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,914,481 shares.
The largest 10 holders included
VANGUARD GROUP INC, Aisling Capital Management LP, BlackRock Inc., STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, Telemetry Investments, L.L.C., NORTHERN TRUST CORP, BARCLAYS PLC, UBS Group AG, and CITIGROUP INC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.